FindTrial
Sign In

To Study the effect of Phalatrikadi Kwath in the management of Urdhwaga Amlapitta in the patient of age group between 20-60 years for 15 days.

A Randomised Standard Controlled clinical trial to evaluate the efficacy of Phalatrikadi Kwath in the management of Urdhwaga Amlapitta.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047732
Enrollment
70
Registered
2022-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

PDEAs College Of Ayurveda and Research Centre, Sector no 25, Nigdi ,Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having five or more following signs and symptoms of Urdhwaga Amlapitta described in Madhav nidan minimum since 15 days - 1. Chhardi ( Vomiting ) 2. Amlodgar (Flatulence) 3. Hrullas (Nausea) 4. Hrit-Kantha Daha 5. Udardaha (Burning sensation in the stomach) 6. Shirashool (headache) 7. Hastapadadaha (Burning sensation in foot and hands) 8. Aruchi (Loss of appetite) 9. Mandalotpatti (urticarial rash)

Exclusion criteria

Exclusion criteria: 1. The known case of Gastric ulcer, duodenal ulcer, Stomach cancer, cancer of esophagus, esophageal varices, hematemesis. 2. Patients with long term use of steroids and pain killers. 3. Sever malnourished patients. 4. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy between Phalatrikadi Kwath and Bhunimbadi Kwath in the management of Urdhwaga Amlapitta for 15 days for the symptoms like Chhardi (vomiting),Amlodgar (Flatulence), Hrullas (Nausea) etc..Timepoint: 15 days with follow up on 7th and 15th day—

Secondary

MeasureTime frame
1. To study the efficacy of Phalatrikadi Kwath in the management of Urdhwaga Amlapitta for 15 days 2. To observe the adverse effect if anyTimepoint: 1. 15 days with follow up on 7th and 15th day—

Countries

India

Contacts

Public ContactDr Vaibhav Sanjay Chaudhari

PDEAs College Of Ayurveda and Research Centre, Nigdi ,Pune

medhamaheshjoshi@gmail.com9881465798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026